Sunday, May 18, 2008

Tamoxifen Non-Compliance in Breast Cancer

Doctors are worried about non-compliance in breast cancer treatment. While compliance with radiation and chemotherapy is still high, nearly 40% of patients are not complying with Tamoxifen treatment. Compliance is especially poor in young breast cancer patients. The authors consider Tamoxifen hormone therapy as the best treatment and sometimes only effective treatment for many patients, making non-compliance a serious health risk.